Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Spectrum Advanced Hand Sanitizer Foam is an alcohol-based topical antiseptic developed by Medline Industries for infection prevention and hand hygiene. Formulated as a foam containing 70% ethyl alcohol (v/v), it is designed to eliminate 99.99% of common harmful germs and bacteria within 15 seconds. The product is specifically engineered for healthcare settings, featuring compatibility with chlorhexidine gluconate (CHG) and the inclusion of moisturizers to maintain skin integrity during frequent use. Its antimicrobial action is mediated through the denaturation of proteins and the disruption of cellular membranes in microorganisms. Clinical evaluation (NCT05740332) has focused on validating the 'wet time' of the foam to ensure compliance with CDC and WHO guidelines, which recommend that hands remain wet for at least 15 seconds during application.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Spectrum Advanced Hand Sanitizer Foam.